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pichlorohydrin (1-chloro-2,3,-epoxypropane) is a colorless liquid used for the manufacture of epoxy resins, surface active agents, adhesives, paints, varnishes, insecticides, and other agricultural chemicals. Absorption through inhalation and skin is of practical importance. ECH is a strong irritant of the eyes, respiratory tract, and skin. Eye and skin irritation/sensitization was observed in laboratory animals. 1 Repeated or prolonged exposure can also cause lung, liver, and kidney damage in experimental animals. 1 According to one industrial report, eye and nasal burning results from 20 ppm ECH exposure; lung edema and renal lesions could result from exposures greater than 100 ppm; and liver damage could occur after exposure to very high concentration levels. 2 Occasional cases of skin irritation or sensitization have been reported in the workplace. [3] [4] [5] However, human epidemiologic studies have not provided definitive evidence of an association between occupational ECH exposure and an increased incidence of organ injury or disease. 1 Recent studies have indicated that metabolic traits might modulate the toxic effects of various chemicals. Genetic polymorphisms have been detected in a variety of enzymes involved in the metabolism of exogenous chemicals and have been associated with varying degrees of environmental disease causation. Animal studies have shown that ECH could be conjugated with glutathione to become N-acetyl-S-(2,3-dihydroxypropyl) cysteine and N,NЈ-bis-acetyl-S-S'-(1,3-biscysteinyl) propane-2-ol. 6 Epoxides have been reported to be substrates for glutathione S-transferase, 7 and GSTM1 and GSTT1 polymorphisms have been reported. 8 Our previous report showed GSTM1 null genotype was found to be associated with increased SCE frequency in ECH-exposed workers. 9 Thus, ECH workers with susceptible GSTM1 could be associated with increased respiratory function damage. Another previous study also suggested that obstructive lung abnormalities and small airway lung damage were associated with ECH exposure. 10 The study also suggested that exposure to very low concentrations (Ͻ0.2 ppm) caused significant higher prevalence of respiratory tract irritation symptoms. 10 In this study, we furthermore investigated the modulatory effects of GSTM1 on ECH-induced respiratory damage.
Materials and Methods
In October 1996, a total of 68 males from 3 workstations of a resin synthesis factory where epoxy resin (workstation I), printed circuit (PC) boards (workstation II), and artificial leather (workstation III) were manufactured were recruited for this study. Personal and area air sampling was performed to determine ECH, dimethylformamide (DMF), and toluene concentrations of workers, and details have been published elsewhere. 11 Briefly, a total of 21 area sampling points were selected throughout the plant based on proximity to sources of solvent emissions. Sampling time ranged from 30 to 180 minutes. Forty-five workers were also selected at random for personal sampling.
Most workers engaged in epoxy resin manufacturing were considered to have increased ECH exposure, most workers in the PC board plant were considered to have both ECH Ten milliliters of venous blood were drawn into heparinized tubes (Vacutainer) and stored at 4°C. The whole blood was separated into plasma, buffy coat, and red blood cells by centrifugation within 18 hours of obtaining the blood and then stored in a -70°C freezer. Genome DNA was extracted and purified from buffy coat. The GSTM1 and GSTT1 genotypes were determined by coamplification of both genes 12, 13 with polymerase chain reaction (PCR). Briefly, PCR was performed in a 25-L mixture containing the buffer supplied by Promega (Madison, WI), 250 ng of genomic DNA, Tag DNA polymerase (1U), 4 bases (dNTP), and 200 g of each of the primers. The primers used for the GST M1 gene were 5Ј-CTGC-CCTACTTGA-TTGA TGGG-3Ј and 5Ј-CTGGATTGTAGCAGAT-CATGC-3Ј. The primers used for the GSTT1 gene were 5Ј-TTCCTTACT-GGTCCTCACATCT C-3Ј and 5Ј-TCACC-GGATCATGGCCAGCA-3Ј. The human B-globin gene (110 bp) was also amplified in each reaction as a positive control to confirm the presence of amplifiable DNA in the samples. The primers used for B-globin were 5Ј-ACACAACT GT GTTCACTAG-C-3Ј and 5Ј-CAACTCATCCACGTTCACC-3Ј. The amplification was carried out 35 cycles with denaturation at 94°C for 1 minute 30 seconds, annealing at 52°C for 1 minute, and extension at 65°C for 1 minute. The PCR products were then resolved by electrophoresis in 2% agarose gels, stained with ethidium bromide, and photographed under ultraviolet light. Individuals with one or more GSTM1 alleles had a 273-bp fragment, and individuals with one or more GSTT1 alleles had a 480-bp fragment.
The data from the 68 workers were encoded, entered, and analyzed with the assistance of the Statistical Analysis System (SAS) PC software package 14 and Database III plus. 15 We used t test to test the differences among the working sections and controls in means of the percentage of predicted forced vital capacity (FVC) value, the percentage of the predicted forced expiratory volume in 1 second (FEV 1 ), forced expiratory volume in 1 second as a percentage of FVC (FEV 1 /FVC), and the percentage of the predicted mean midexpiratory flow (MMEF). Multivariate regression analysis was used to control for the effects of potential confounders on the association between exposure groups, GSTM1 status, and lung function tests.
Results
The basic characteristics of 68 male workers are summarized in Table 1. The average ECH exposure concentration was 1.22 ppm (range, 0.2-3.9 ppm) in the high-exposure group and 0.078 ppm (range, 0.01-0.11 ppm) in the low-exposure group. The non-ECH-exposure workers seemed to be significantly older than the high-exposure workers and also had a significantly longer duration of employment than others. There were significantly lower values for average lung function tests (FEV 1 , MMEF) in high ECH-exposure workers than in the non-ECHexposure group (FEV 1 94.2 Ϯ 11.6% vs. 101.2 Ϯ 8%; MMEF 72.8 Ϯ 18.5% vs. 83.9 Ϯ 13%). There were significantly lower values for average lung function tests (MMEF) in low ECH-exposure workers than in the non-ECH-exposure group (MMEF 69.9 Ϯ 20% vs. 83.9 Ϯ 13%). Because lung function tests (FEV 1 , FEV 1 /FVC, MMEF) were not significantly different between the high and low ECH-exposed groups, data on lung function tests of these 2 groups were combined for further analysis.
The overall prevalences of GSTM1 null genotype and GSTT1 null genotype were 51.5% and 42.7%, respectively. The characteristics of workers by GSTM1 status and GSTT1 status were shown in Tables  2 and 3 . GSTM1 null genotype workers had significantly lower values for average lung function tests (FEV 1 , FEV 1 /FVC, MMEF) than the GSTM1 non-null genotype workers (FEV 1 92.6 Ϯ 11.2% vs. 99.5 Ϯ 11.6%; FEV 1 /FVC 85.9 Ϯ 9.5% vs. 89.9 Ϯ 5.6%, MMEF 69 Ϯ 18.1%vs. 80.6 Ϯ 17.1%) ( Table 2 ). GSTM1 non-null genotype workers had significant more heavy smokers than GSTM1 null genotype workers (P Ͻ0.1). In the 2 GSTT1 genotype groups, the lung function tests (FEV 1 , FEV 1 /FVC, MMEF), age, duration of employment, smoking status, and (ECH, toluene, DMF) exposure concentration were not different (Table 3) .
The average FEV 1 , FEV 1 /FVC, and MMEF value stratified by GSTM1 status and categories of ECH exposure are shown in Table 4 . Among the ECH-exposure group, GSTM1 null genotype workers had significantly lower values for average lung function tests (FEV 1 , FEV 1 / FVC, MMEF) than the GSTM1 nonnull genotype workers. Among the non-ECH-exposure group, the average lung function tests (FEV 1 , FEV 1 / FVC, MMEF) were not different in the 2 GSTM1 genotype workers. Among the GSTM1 null genotype group, the ECH-exposed workers had significantly lower values for average lung function tests (FEV 1 , FEV 1 /FVC, MMEF) than the non-ECH-exposed workers. Among the GSTM1 non-null genotype group, the average lung function tests (FEV 1 , FEV 1 /FVC, MMEF) were not different in the 2 ECH-exposed workers.
Multiple regression analysis was performed to analyze the relationships of lung function tests with potential explanatory indicators, including duration of employment, smoking, ECH exposure, DMF exposure, Toluene exposure, and the inherited metabolic traits conferred by GSTM1 genes (Table 5) . ECH exposure was found to be significantly associated with decreased average MMEF value (P ϭ 0.053) and decreased average FEV 1 value (P ϭ 0.09) after adjusting for other factors. The GSTM1 null genotype was found to be significantly associated with a decreased FEV 1 value (P ϭ 0.038), decreased FEV 1 /FVC value (P ϭ 0.056), and decreased MMEF value (P ϭ 0.012) after adjusting for other factors.
Discussion
Our study showed that ECH exposure was found to be significantly associated with decreased average MMEF value and decreased average FEV 1 value, suggesting that obstructive lung function abnormalities and small airway lung damage were associated with ECH exposure.
The mammalian GST supergene family is composed of ␣, , , and and catalyzes the conjugation of GSH with electrophilic substrates. Some individuals carry a large deletion (null genotype) in glutathione S-transferase (GSTM1) gene and glutathione S-transferase (GSTT1) gene. Individuals with the GSTM1 or GSTT1 null genotype are expected to detoxify environmental toxicants less effectively, thus increasing the concentrations of toxic metabolites in plasma and affecting the clinical outcomes. An individual without an intact GSTM1 could have a higher risk of developing cancer or cytogenetic damage. 16 -18 Adverse effects of maternal exposure to environmental tobacco smoke on neonatal birth weight could be modified by the maternal metabolic genotypes, GSTM1 and GSTT1. 19 Our previous report showed that GSTM1 null genotype was associated with increased SCE frequency in ECH-exposed workers. 9 This study suggests that ECH workers with susceptible genotypes (GST M1 null-type) have increased respiratory damage, including small airways and obstructive lung function. The GSTM1 null genotype was significantly associated with decreased average MMEF value, decreased average FEV 1 value, and decreased average FEV 1 / FVC value. In contrast, GSTT1 genotypes were not associated with lung function tests. Many chemicals have been found to be substrates for GSTT1, including ethylene oxide, dihaloalkalane, and diepoxybutane. 20 -22 It is not clear if ECH is metabolized by GSTT1.
Small airways under 2 mm in diameter are the primary site of deposition of poorly soluble inhaled toxins and can be affected earliest and most severely. MMEF is a simple, sensitive, and early indicator of obstruction in smaller airways 23, 24 Methacholine inhalation provocation tests are noted to be helpful in evaluating an asymptomatic individual worker with suspected occupational asthma or identifying workers with already hyperreactive airways who might be at greater risk for disease [25] [26] [27] [28] Seventeen of 51 (33.3%) ECH-exposed workers had obstructive (FEV 1 Ͻ 80% or FEV 1 /FVC Ͻ75%) or small airway lung lesions (MMEF Ͻ 60%), 5 of them received provocation tests, and 2 (40%) workers proved to have a hypersensitive airway. One of them is a 33-year-old male maintenance worker with 5 years on his job and 1.1 ppm ECH exposure. He complained of cough with phlegm, chest tightness, wheezing, and dyspnea for at least the past 3 months. His obstructive lung abnormalities returned to normal 5 months later (FEV 1 /FVC 53.4% 3 86.5%; FEV 1 69.4% -Ͼ72.6%, MMEF 50.7% 3 64%) after medical treatment and by avoiding unnecessary exposure through adequate personal respiratory protection and proper engineering controls in the plant. Another hyperactive airway worker with 0.2 ppm ECH exposure also had better lung function (MMEF 53.5% -Ͼ 65%) after 5 months intervention. During the 5 months of follow up, the lung function of 2 of 3 negative provocation workers also had recovered for the same reasons. These results indicate that ECH might cause reversible obstructive lung abnormalities through airway irritation and inflammation and also might cause hyperactive airways.
Respiratory tract irritants represent a diverse spectrum of compounds, gases, and chemicals that, when inhaled, result in irritation to mucous membranes manifested as nonspecific inflammation. The water solubility and concentration of the irritants determine the site of injury. Extremely water-soluble compounds such as ammonia cause injury in the upper airway, whereas insoluble gases such as the nitrogen oxides cause peripheral airway and alveolar injury. ECH is a less soluble gas with a 6.48% water solubility, which might explain its effect on the lower respiratory tract and not on the upper airway.
The precise mechanism of ECHinduced airway abnormalities is still unclear. Studies on the other less water-soluble gases such as nitrogen oxides and ozone could shed light on this. Studies in animal models show that nitrogen dioxide exposure could produce morphologic alterations in the terminal and respiratory bronchioles and adjacent alveolar ducts and alveoli. 29 -34 Within the ciliated cells of bronchiolar epithelium, acute exposure results in hypertrophy and hyperplasia of the type 1 cells followed by death and desquamation of these cells and proliferation and replacement by type 2 cells and causes a thickened air-blood barrier. Chronic exposure could result in alterations in lung architecture resembling those of emphysema. 35, 36 Studies of ozone described inflammatory and biochemical changes in the airways after ozone exposure. [37] [38] [39] Ozone-induced airway reactivity to methacholine was associated with polymorphonuclear leukocyte (PMN) influx into airways with interleukin 8 and changes in cyclooxygenase metabolites of arachidonic acid. DMF is not noted to cause pulmonary function abnormality and respiratory tract irritation. Workers with toluene exposures between 200 and 800 ppm might have respiratory and ocular irritation. 40, 41 In this study, toluene concentration was not high enough to cause any lung damage, and DMF concentrations should have had no respiratory effect either. Smoking was noted to cause obstructive lung function abnormalities. [42] [43] [44] [45] In this study, there was no significant relationship between small airway abnormalities or obstructive lung abnormalities and smoking status. The crude estimation of smoking status could have contributed to this finding. Further precise delineation of smoking patterns might be able to clarify this effect.
This study is limited by its small sample size and results (with borderline significance and confidence intervals less than 1), which indicate that obstructive lung abnormalities, small airway lung damage are associated with ECH exposure, and ECH workers with GSTM1 null-type could be associated with increased respiratory damage. The study also indicates that exposure to very low concentrations (Ͻ0.2 ppm), which are far below the current OSHA TLV of 2 ppm, can cause small airway lung dysfunction. Further studies are needed to better clarify the nature of the observed association.
